A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-Induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel

Lahat, Hadas, Pras, Elon, Olender, Tsviya, Avidan, Nili, Ben-Asher, Edna, Man, Orna, Levy-Nissenbaum, Etgar, Khoury, Asad, Lorber, Avraham, Goldman, Boleslaw, Lancet, Doron, Eldar, Michael·2001·The American Journal of Human Genetics
DOI 10.1086/324565

Cited by (653)

Items 201–300 of 653

  1. Molecular genetic basis of sudden cardiac death
    Jeffrey Allen Towbin · 2001 · Cardiovascular Pathology
  2. Genetic testing in heritable cardiac arrhythmia syndromes
    John R. Giudicessi, Michael John Ackerman · 2012 · Current Opinion in Cardiology
  3. Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Associated With Ryanodine Receptor (RyR2) Gene Mutations – Long-Term Prognosis After Initiation of Medical Treatment –
    Hiro Kawata, Seiko Ohno, Takeshi Aiba, Heima Sakaguchi, Aya Miyazaki, Naokata Sumitomo, Tsukasa Kamakura, Ikutaro Nakajima, Yuko Y. Inoue, Koji Miyamoto et al. · 2016 · Circulation Journal
  4. Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects
    Masa‐aki Kawashiri, Kenshi Hayashi, Tetsuo Konno, Noboru Fujino, Hidekazu Ino, Masakazu Yamagishi · 2013 · Heart and Vessels
  5. Genetics of ion-channel disorders
    Marina Cerrone, Carlo Napolitano, Silvia Giuliana Priori · 2012 · Current Opinion in Cardiology
  6. Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice
    Guy Katz, Assad Khoury, Efrat Kurtzwald-Josefson, Edith Hochhauser, Eyal E. Porat, Asher Shainberg, Jonathan G. Seidman, Christine E. Seidman, Abraham Lorber, Michael Eldar et al. · 2010 · Heart Rhythm
  7. Clinical Spectrum and Prognostic Factors of Pediatric Ventricular Tachycardia
    Mikyoung Song, Jae-Suk Baek, Bo-Sang Kwon, Gi Beom Kim, Eun-Jung Bae, Chung-Il Noh, Jung-Yun Choi · 2010 · Circulation Journal
  8. Sodium Calcium Exchange as a Target for Antiarrhythmic Therapy
    Karin R. Sipido, András Varró, David A. Eisner · 2006 · Springer eBooks
  9. Deep learning of left atrial structure and function provides link to atrial fibrillation risk
    James P. Pirruccello, Paolo Di Achille, Seung Hoan Choi, Joel T Rämö, Shaan S. Khurshid, Mahan Nekoui, Sean Joseph Jurgens, Victor Nauffal, Shinwan Kany, FinnGen et al. · 2024 · Nature Communications
  10. Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy
    Hiroshi Watanabe, Björn C. Knollmann · 2011 · Journal of Electrocardiology
  11. Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin
    Giorgia Valle, Daniela Galla, Alessandra Nori, Silvia Giuliana Priori, Sándor Györke, Vincenzo De Filippis, Pompeo Volpe D · 2008 · Biochemical Journal
  12. Identification of Novel Missense Mutations of Cardiac Ryanodine Receptor Gene in Exercise-Induced Sudden Death at Autopsy
    Wendy Creighton, Renu Virmani, Robert Kutys, ALLEN P. BURKE · 2006 · Journal of Molecular Diagnostics
  13. Cardiac Ion Channelopathies and the Sudden Infant Death Syndrome
    R. Wilders · 2012 · ISRN Cardiology
  14. Susceptibility genes and modifiers for cardiac arrhythmias
    Stefan Kääb, Eric Schulze‐Bahr · 2005 · Cardiovascular Research
  15. Catecholaminergic polymorphic ventricular tachycardia
    Kaisa Ylänen, Tuija Poutanen, Anita Hiippala, Heikki Swan, Matti O. Korppi · 2010 · European Journal of Pediatrics
  16. Calsequestrin, a key protein in striated muscle health and disease
    Daniela Rossi, Alessandra Gamberucci, Enrico Pierantozzi, Caterina Amato, Loredana Migliore, Vincenzo Sorrentino · 2020 · Journal of Muscle Research and Cell Motility
  17. The role of genetic testing in unexplained sudden death
    Chris J. Miles, Elijah Raphael Behr · 2015 · Translational research
  18. Calsequestrin. Structure, function, and evolution
    Qian Wang, Marek Michalak · 2020 · Cell Calcium
  19. The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases
    Andrea Mazzanti, Sean O’Rourke, Kevin Kit Ng, Carlotta Miceli, Gianluca Borio, Antonio Curcio, Francesca Esposito, Carlo Napolitano, Silvia Giuliana Priori · 2014 · Expert Review of Cardiovascular Therapy
  20. RYR2 and CASQ2 Mutations in Patients Suffering From Catecholaminergic Polymorphic Ventricular Tachycardia
    Hadas Lahat, Elon Pras, Michael Eldar · 2003 · Circulation
  21. Acute atrial arrhythmogenicity and altered Ca2+ homeostasis in murine RyR2-P2328S hearts
    Yanmin Zhang, James A. Fraser, Kamalan Jeevaratnam, Xiaojin Hao, Sandeep Singh Hothi, Andrew A. Grace, Ming Lei, Christopher L.-H. Huang · 2010 · Cardiovascular Research
  22. Gene therapy for inherited arrhythmias
    Vassilios J. Bezzerides, Maksymilian Prondzynski, Lucie Carrier, William T. Pu · 2020 · Cardiovascular Research
  23. JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
    Ono K, Yu‐ki Iwasaki, Masaharu Akao, Takanori Ikeda, Kuniaki Ishii, Yasuya Inden, Kengo Kusano, Yoshinori Kobayashi, Yukihiro Koretsune, Tetsuo Sasano et al. · 2022 · Journal of Arrhythmia
  24. Autonomic control of ventricular function in health and disease: current state of the art
    Valerie Y. H. van Weperen, Crystal M. Ripplinger, Marmar Vaseghi · 2023 · Clinical Autonomic Research
  25. Inherited Arrhythmias in the Pediatric Population: An Updated Overview
    Marco Valerio Mariani, Nicola Pierucci, Francesca Fanisio, Domenico Laviola, Giacomo Silvetti, Agostino Piro, Vincenzo Mirco La Fazia, Cristina Chimenti, Marco Rebecchi, Fabrizio Drago et al. · 2024 · Medicina
  26. Gender Differences in the Inheritance Mode of RYR2 Mutations in Catecholaminergic Polymorphic Ventricular Tachycardia Patients
    Seiko Ohno, Kanae Hasegawa, Minoru Horie · 2015 · PLoS ONE
  27. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling
    Uwe Kirchhefer, Diana Wehrmeister, Alex Vincent Postma, Gottfried Pohlentz, Michael Mormann, Dana Kucerova, Frank Ulrich Müller, Wilhelm Ludolf Schmitz, Eric Schulze‐Bahr, Arthur A.M. Wilde et al. · 2010 · Journal of Molecular and Cellular Cardiology
  28. Sudden death in epilepsy: the overlap between cardiac and neurological factors
    Nathan A. Shlobin, Roland D. Thijs, David G. Benditt, Katja Zeppenfeld, Josemir W. A. S. Sander · 2024 · Brain Communications
  29. Knocking Down Type 2 but Not Type 1 Calsequestrin Reduces Calcium Sequestration and Release in C2C12 Skeletal Muscle Myotubes
    Ying Wang, Le Xu, Hongzhe Duan, Daniel A. Pasek, Jerry P. Eu, Gerhard Meissner · 2006 · Journal of Biological Chemistry
  30. Genomic approaches to identify and investigate genes associated with atrial fibrillation and heart failure susceptibility
    Kush Ketan Patel, Cynthia Venkatesan, Habiba Abdelhalim, Saman Zeeshan, Yuichiro Arima, Suvi Linna-Kuosmanen, Zeeshan Ahmed · 2023 · Human Genomics
  31. C-terminal residues of skeletal muscle calsequestrin are essential for calcium binding and for skeletal ryanodine receptor inhibition
    Nicole A. Beard, Angela Fay Dulhunty · 2015 · Skeletal Muscle
  32. Utility of the Exercise Electrocardiogram Testing in Sudden Cardiac Death Risk Stratification
    Marwan M. Refaat, Mostafa Hotait, Zian H. Tseng · 2014 · Annals of Noninvasive Electrocardiology
  33. Catecholaminergic Polymorphic Ventricular Tachycardia
    Chan Wook Kim, Wilbert S. Aronow, Tanya Dutta, Daniel Frenkel, William H. Frishman · 2020 · Cardiology in Review
  34. Human Genomics and Its Impact on Arrhythmias
    Dan M. Roden · 2004 · Trends in Cardiovascular Medicine
  35. The Fifteen Years of Discoveries That Shaped Molecular Electrophysiology
    Silvia Giuliana Priori · 2010 · Circulation Research
  36. Ion Channels in the Heart
    Daniel C Bartos, Eleonora Grandi, Crystal M. Ripplinger · 2015 · Comprehensive Physiology
  37. SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmias
    Shiraz Haron‐Khun, David Weisbrod, Hanna Bueno, Dor Yadin, Joachim A. Behar, Asher S. Peretz, Ofer Binah, Edith Hochhauser, Michael Eldar, Yael Yaniv et al. · 2017 · EMBO Molecular Medicine
  38. Sudden cardiac death: Prevalence, pathogenesis, and prevention
    Martina Montagnana, Giuseppe Lippi, Massimo Franchini, Giovanni Targher, Gian Cesare Guidi · 2008 · Annals of Medicine
  39. Inherited Arrhythmia Syndromes: Applying the Molecular Biology and Genetic to the Clinical Management
    Silvia Giuliana Priori, Carlo Napolitano, Alessandro Vicentini · 2003 · Journal of Interventional Cardiac Electrophysiology
  40. Catecholaminergic polymorphic ventricular tachycardia: An exciting new era
    Shashank Prakash Behere, StevenN Weindling · 2016 · Annals of Pediatric Cardiology
  41. The Purkinje–myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT
    Daniel J. Blackwell, Michela Faggioni, Matthew J. Wleklinski, Nieves Gómez‐Hurtado, Raghav Venkataraman, Chelsea E Gibbs, Franz J. Baudenbacher, Shiaoching Gong, Glenn I. Fishman, Patrick M. Boyle et al. · 2022 · JCI Insight
  42. Calsequestrin Distribution, Structure and Function, Its Role in Normal and Pathological Situations and the Effect of Thyroid Hormones
    P. NOVÁK, T. Soukup · 2011 · Physiological Research
  43. Sudden Cardiac Death
    Robert J. Myerburg, Alberto Interian, Jeffrey D. Simmons, Agustín Castellanos · 2004 · Elsevier eBooks
  44. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature
    C. Pott, Dirk Georg Dechering, Florian Reinke, A. Muszynski, Stephan Zellerhoff, Alex Bittner, Julia Köbe, Kristina Wasmer, Eric Schulze‐Bahr, Gerold Mönnig et al. · 2011 · EP Europace
  45. Channelopathies as Causes of Sudden Cardiac Death
    Peter J. Schwartz, Michael John Ackerman, Arthur A.M. Wilde · 2017 · Cardiac Electrophysiology Clinics
  46. A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family
    Lijian Xie, Cuilan Hou, Xunwei Jiang, Jian Zhao, Yun Li, Tingting Xiao · 2019 · European Journal of Medical Genetics
  47. Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships
    Damilola Olubando, Claire Hopton, James Eden, Richard C. Caswell, Nia Lowri Thomas, Stephen A. Roberts, Deborah J. Morris-Rosendahl, Luigi A. Venetucci, William G. Newman · 2020 · Journal of Human Genetics
  48. Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia
    Zhipeng Sun, Luqi Wang, Lu Han, Yue Wang, Yuan Zhou, Qiang Li, Yongquan Wu, Shaletanati Talabieke, Yunlong Hou, Lulin Wu et al. · 2021 · Circulation
  49. Role of Junctin Protein Interactions in Cellular Dynamics of Calsequestrin Polymer upon Calcium Perturbation
    Keun Woo Lee, Jin‐Soo Maeng, Jeong Yi Choi, Yu Ran Lee, Chae Young Hwang, Sung Sup Park, Hyun Kyu Park, Bong Hyun Chung, Seung‐Goo Lee, Yeon-Soo Kim et al. · 2011 · Journal of Biological Chemistry
  50. The variation of the sarcolipin gene (SLN) in atrial fibrillation, long QT syndrome and sudden arrhythmic death syndrome
    M.T. Nyberg Godiksen, Birgitte Stoevring, Elijah Raphael Behr, Lasse Steen Ravn, William John McKenna, Michael Christiansen · 2006 · Clinica Chimica Acta
  51. Lessons from calsequestrin-1 ablation in vivo: much more than a Ca2+ buffer after all
    Feliciano Protasi, Cecilia Paolini, Marta Canato, Carlo Reggiani, Marco Quarta · 2011 · Journal of Muscle Research and Cell Motility
  52. Clinical Management of Ventricular Tachycardia
    Cara N. Pellegrini, Melvin M. Scheinman · 2010 · Current Problems in Cardiology
  53. Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathy
    Philippe Le Corvoisier · 2003 · Human Molecular Genetics
  54. Cardiac channelopathies: from men to mice
    Flavien Charpentier, Sophie Demolombe, Denis Escande · 2004 · Annals of Medicine
  55. Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies
    Ruey J. Sung, Hsiao, Tien, Chu‐Pin Lo, Jyh‐Ming Jimmy Juang, Yi-Hsin Wang · 2013 · The Application of Clinical Genetics
  56. Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: A simulation study of cellular mechanism
    Gregory M. Faber, Yoram Rudy · 2007 · Cardiovascular Research
  57. Comprehensive expression profiling by muscle tissue class and identification of the molecular niche of extraocular muscle
    Sangeeta Khanna, Anita P. Merriam, Bendi Gong, Patrick S. Leahy, John D. Porter · 2003 · The FASEB Journal
  58. Next-Generation Sequencing in Post-mortem Genetic Testing of Young Sudden Cardiac Death Cases
    N. Lahrouchi, E. Behr, C. Bezzina · 2016 · Frontiers in Cardiovascular Medicine
  59. Calcium Channelopathies: Structural Insights into Disorders of the Muscle Excitation–Contraction Complex
    Raika Pancaroglu, Filip Van Petegem · 2018 · Annual Review of Genetics
  60. New drugs vs. old concepts: A fresh look at antiarrhythmics
    Jérôme Thireau, Jean‐Luc Pasquié, Eric Martel, Jean‐Yves Le Guennec, Sylvain Richard · 2011 · Pharmacology & Therapeutics
  61. Ryanodine receptor (RyR2) mutations in sudden cardiac death: Studies in extended pedigrees and phenotypic characterization in vitro
    Annukka Marjamaa, Päivi J. Laitinen-Forsblom, Anetta Wronska, Lauri K. Toivonen, KIMMO K. KONTULA, Heikki Swan · 2009 · International Journal of Cardiology
  62. The molecular basis of catecholaminergic polymorphic ventricular tachycardia: What are the different hypotheses regarding mechanisms?
    Xander H.T. Wehrens · 2006 · Heart Rhythm
  63. A Clinical Approach to Inherited Arrhythmias
    Marina Cerrone, Samori Cummings, Tarek H. Alansari, Silvia Giuliana Priori · 2012 · Circulation Cardiovascular Genetics
  64. The CPVT-associated RyR2 mutation G230C enhances store overloadinduced Ca2+ release and destabilizes the N-terminal domains
    Yingjie Liu, Lynn Kimlicka, Florian Hiess, Xixi Tian, Ruiwu Wang, Lin Zhang, Peter P. Jones, Filip Van Petegem, S.R. Wayne Chen · 2013 · Biochemical Journal
  65. Calcium sparks in the heart: dynamics and regulation
    Mohsin Saleet Jafri, Aman Ullah, Tuan M. Hoang-Trong · 2015 · Research and Reports in Biology
  66. Novel regulators of RyR Ca2+ release channels: insight into molecular changes in genetically-linked myopathies
    Angela Fay Dulhunty, Nicole A. Beard, Pierre Pouliquin, Takashi Kimura · 2006 · Journal of Muscle Research and Cell Motility
  67. Calcium cycling proteins in heart failure, cardiomyopathy and arrhythmias
    Susumu Minamisawa, Yoji Sato, Myeong‐Chan Cho · 2004 · Experimental & Molecular Medicine
  68. Molecular Mechanisms of Inherited Arrhythmias
    Cordula Maria Wolf, Charles I. Berul · 2008 · Current Genomics
  69. Modulation of Human Ether A Gogo Related Channels by CASQ2 Contributes to Etiology of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
    Karina Eckey, Nathalie Strutz‐Seebohm, Guy Katz, Gloria Fuhrmann, Ulrike Henrion, Lutz Pott, Wolfgang Albrecht Linke, Michael Arad, Florian J.W. Lang, Guiscard Seebohm · 2010 · Cellular Physiology and Biochemistry
  70. The Calsequestrin Mutation CASQ2D307H Does Not Affect Protein Stability and Targeting to the Junctional Sarcoplasmic Reticulum but Compromises Its Dynamic Regulation of Calcium Buffering
    Anuradha Kalyanasundaram, Naresh Chandra Bal, Clara Franzini‐Armstrong, Björn C. Knollmann, Muthu Periasamy · 2009 · Journal of Biological Chemistry
  71. Electrophysiological Interventions for Inherited Arrhythmia Syndromes
    Elizabeth A. Stephenson, Charles I. Berul · 2007 · Circulation
  72. Constitutive Intracellular Na + Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia
    B. Cicero Willis, Sandeep V. Pandit, Daniela Ponce‐Balbuena, Manuel Zarzoso, Guadalupe Guerrero‐Serna, Bijay Limbu, Makarand Deo, Emmanuel M. Camors, Rafael J. Ramírez, Sergey F. Mironov et al. · 2016 · Circulation
  73. Diretrizes Brasileiras de Dispositivos Cardíacos Eletrônicos Implantáveis (DCEI)
    2007 · Arquivos Brasileiros de Cardiologia
  74. Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants
    Naresh Chandra Bal, Nivedita Jena, Danesh H. Sopariwala, Tuniki Balaraju, Sana J. Shaikh, Chandralata Bal, Ashoke Sharon, Sándor Györke, Muthu Periasamy · 2011 · Biochemical Journal
  75. Cardiac arrhythmias and sudden death in infancy: implication for the medicolegal investigation
    Horst Wedekind, Eric Schulze‐Bahr, Volker Debus, GÜNTER E. BREITHARDT, Bernd Brinkmann, Thomas Bajanowski · 2006 · International Journal of Legal Medicine
  76. Electrocardiographic Comparison of Ventricular Premature Complexes during Exercise Test in Patients with CPVT and Healthy Subjects
    Miry Blich, IBRAHIM MARAI, Mahmoud A. Suleiman, Avraham Lorber, Lior Gepstein, Monther Boulous, Asaad Khoury · 2015 · Pacing and Clinical Electrophysiology
  77. Tricyclic antidepressant amitriptyline alters sarcoplasmic reticulum calcium handling in ventricular myocytes
    Aleksey V. Zima, Jia Qin, Michael Fill, Lothar A. Blatter · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
  78. Importance of Ventricular Tachycardia Storms Not Terminated by Implantable Cardioverter Defibrillators Shocks in Patients With CASQ2 Associated Catecholaminergic Polymorphic Ventricular Tachycardia
    Ibrahim Marai, Asaad Khoury, Mahmoud A. Suleiman, Lior Gepstein, Miri Blich, Abraham Lorber, Monther Boulos · 2012 · The American Journal of Cardiology
  79. Postmortem genetic testing of the ryanodine receptor 2 (RYR2) gene in a cohort of sudden unexplained death cases
    Mogens Larsen, Knut Erik Berge, Trond P. Leren, Peter H. Nissen, Jakob Hansen, Ida Bruun Kristensen, Jytte Banner, Henrik Kjærulf Jensen · 2012 · International Journal of Legal Medicine
  80. Molecular genetic basis of sudden cardiac death
    Jeffrey Allen Towbin · 2004 · Pediatric Clinics of North America
  81. Stress and high heart rate provoke ventricular tachycardia in mice expressing triadin
    Paulus F. Kirchhof, Ján Klimas, Larissa Fabritz, Melanie Zwiener, Larry R. Jones, Michael Andreas Schäfers, Sven Hermann, Peter Boknı́k, Wilhelm Ludolf Schmitz, GÜNTER E. BREITHARDT et al. · 2007 · Journal of Molecular and Cellular Cardiology
  82. Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations
    Anders Krogh Broendberg, Jens Cosedis Nielsen, Jesper Vandborg Bjerre, Lisbeth Noerum Pedersen, Jens Kristensen, Finn Lund Henriksen, Henning Bundgaard, Henrik Kjærulf Jensen · 2017 · Heart
  83. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2
    Jing Xiong, Xijun Liu, Yunyun Gong, Peng Zhang, Sujing Qiang, Qian Zhao, Rong Guo, Yunyun Qian, Lipeng Wang, Li Zhu et al. · 2018 · Journal of Molecular and Cellular Cardiology
  84. Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death
    Mark J. Specterman, Elijah Raphael Behr · 2022 · Heart
  85. A Missense Mutation in a Highly Conserved Region of CASQ2 Is Associated with Autosomal Recessive Catecholamine-induced Polymorphic Ventricular Tachycardia in Bedouin Families from Israel
    M. Eldar, Elon Pras, Hadas Lahat · 2002 · Cold Spring Harbor Symposia on Quantitative Biology
  86. Abnormal Excitation-Contraction Coupling and Calcium Homeostasis in Myopathies and Cardiomyopathies
    Vanessa Schartner, Jocelyn Laporte, Johann Böhm · 2019 · Journal of Neuromuscular Diseases
  87. Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
    Michelangelo Paci, Kirsi Penttinen, Mari Pekkanen-Mattila, Jussi T. Koivumäki · 2020 · Journal of Cardiovascular Pharmacology
  88. MicroRNAs and Calcium Signaling in Heart Disease
    Jae‐Ho Park, Changwon Kho · 2021 · International Journal of Molecular Sciences
  89. Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse
    Marine Cacheux, Jérémy Fauconnier, Jérôme Thireau, Alexis Osseni, Jacques Brocard, Nathalie Roux-Buisson, Julie Brocard, Julien Fauré, Alain Lacampagne, Isabelle Marty · 2019 · Molecular Therapy
  90. Genetics of inherited primary arrhythmia disorders
    Michael H. Gollob, DANNA A. SPEARS · 2015 · The Application of Clinical Genetics
  91. Ryanodine receptor mutations in arrhythmia: The continuing mystery of channel dysfunction
    Nia Lowri Thomas, Chloe E. Maxwell, Saptarshi Mukherjee, Alan J. Williams · 2010 · FEBS Letters
  92. Molecular Insights into Calcium Dependent Regulation of Ryanodine Receptor Calcium Release Channels
    Naohiro Yamaguchi · 2019 · Advances in experimental medicine and biology
  93. Molecular Mechanisms of Inherited Ventricular Arrhythmias
    Thomas Wichter, Eric Schulze‐Bahr, Lars Eckardt, Matthias Paul, Bodo Levkau, Matthias Meyborg, Michael Andreas Schäfers, Wilhelm Haverkamp, GÜNTER E. BREITHARDT · 2002 · Herz
  94. Intracellular Calcium Handling Dysfunction and Arrhythmogenesis
    Silvia Giuliana Priori, Carlo Napolitano · 2005 · Circulation Research
  95. Genetics of Cardiac Electrical Disease
    Mark J. Perrin, Michael H. Gollob · 2012 · Canadian Journal of Cardiology
  96. Structure and Function of the Human Ryanodine Receptors and Their Association with Myopathies—Present State, Challenges, and Perspectives
    Vladena Bauerová‐Hlinková, Dominika Hajdúchová, Jacob Bauer · 2020 · Molecules
  97. Modeling heart disease in a dish: From somatic cells to disease-relevant cardiomyocytes
    Fabian Zanella, Robert C. Lyon, Farah Sheikh · 2013 · Trends in Cardiovascular Medicine
  98. Genetic Loss of I K1 Causes Adrenergic-Induced Phase 3 Early Afterdepolariz ations and Polymorphic and Bidirectional Ventricular Tachycardia
    Louise Reilly, Francisco J. Alvarado, Di Lang, Sara H. Abozeid, Hanora A. Van Ert, Cordell Spellman, Jarrett Warden, Jonathan C. Makielski, Alexey V. Glukhov, Lee L. Eckhardt · 2020 · Circulation Arrhythmia and Electrophysiology
  99. Pediatric Catecholaminergic Polymorphic Ventricular Tachycardia: A Translational Perspective for the Clinician-Scientist
    Dania Kallas, Avani Lamba, Thomas M. Roston, Alia Arslanova, Sonia Franciosi, Glen F. Tibbits, Shubhayan Sanatani · 2021 · International Journal of Molecular Sciences
  100. Multiple Actions of the Anthracycline Daunorubicin on Cardiac Ryanodine Receptors
    Amy D. Hanna, Marie Janczura, Eric Cho, Angela Fay Dulhunty, Nicole A. Beard · 2011 · Molecular Pharmacology